Illumina Inc at Cowen Liquid Biopsy Summit (Virtual) Transcript
All right. Good afternoon, everyone. It's my pleasure to welcome Francis deSouza, the Chief Executive Officer of Illumina, to Cowen's Liquid Biopsy Summit. We also, from the company, have Alex Aravanis, the company's Chief Technology Officer.
As it turns out, I wish I could say I planned this, but this has turned out to be a very timely meeting to set up a time to talk to Illumina, given their announcement on Monday that the company plans to acquire GRAIL at a valuation of about $8 billion. So we're going to move away from the format that we use most of the day and just have a 30-minute discussion with Francis. And Alex, he'll chime in, of course, on some of the technical questions to the extent that we have them. So thanks to both of you for being here.
Francis, before I get into it, I think you probably need to read a safe harbor. So I would do that for you if I had it, but if you want to -- if that's something we need to do, why don't we get that out of the way, and then we'll get into the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
